sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÓÕ·¢2ÐÍÌÇÄò²¡¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > ÓÕ·¢2ÐÍÌÇÄò²¡¶¯ÎïÄ£×Ó

ǰÑÔ

ÌÇÄò²¡(diabetes)ÊÇÒ»ÖÖÒòÌåÄÚÒȵºËؾø¶Ô»òÕßÏà¶Ôȱ·¦Ëùµ¼ÖµÄһϵÁÐÁÙ´²×ÛºÏÕ÷£¬ÓëÒÅ´«»ùÒòÓÐןÜÊÇÇ×½üµÄ¹ØÁª¡£ÓÕ·¢ÌÇÄò²¡ÒòËØºÜÖØ´ó£¬ÔÚ´ó×ÚÈËȺÖÐÑо¿ÆÊÎöÕâЩÒòËØÊ®·ÖÄÑÌ⣬Òò´Ë£¬Ñо¿Ä³Ð©¶¯ÎïÖÖϵÌÇÄò²¡±¬·¢µÄ°Ù·ÖÂʼ°ÇéÐÎÒòËØ£¨Ñ¬È¾¡¢¶¾ËØ¡¢Òûʳ¼°Ò©ÎïµÈ£©¶ÔÓÕ·¢¶¯ÎïÌÇÄò²¡¼°Ä³Ð©²¢·¢Ö¢µÄÓ°Ï죬¿ÉΪ·ÀÖÎÈËÀàÌÇÄò²¡ÌṩÖ÷ÒªÏßË÷¡£¶ø¿¹ÌÇÄò²¡ÐÂÒ©µÄÑо¿£¬Ò²ÐëÏÈÊÔÓÃÓÚÌÇÄò²¡¶¯ÎÒÔÆÀ¼ÛÒ©ÎïµÄÁÆÐ§¼°Çå¾²ÐÔ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

2ÐÍÌÇÄò²¡(type 2 diabetes)ϵÒÅ´«ÒòËØÓëÇéÐÎÒòËØÅäÏàÖúÓõÄЧ¹û£¬³ýÓÐѪÌÇÉý¸ßÍ⣬ͬʱ¶à°éÓÐѪ֬Òì³£¡£ÏÖÔÚÓÕ·¢2ÐÍÌÇÄò²¡Ä£×ÓÓ¦ÓÃ×îÆÕ±éµÄÊÇÒ©ÎïÒªÁì¡£¸ø´óÊó×¢ÉäС¼ÁÁ¿STZ£¬Ôì³ÉÒȵºβϸ°ûÇá¶ÈËðÉË£¬Ê¹´ó¶¼¶¯Îﱬ·¢ÌÇÄÍÁ¿Òì³££¬ÔÚ´Ë»ù´¡ÉÏ£¬¸ø¶¯Îïι¸ßÈÈÁ¿ËÇÁÏ£¬ÒýÆð¶¯Îï·ÊÅÖ£¬Í¬Ê±°éÓиßѪ֬¡¢¸ßÒȵºËØÑªÖ¢¼°ÒȵºËØ¿¹ÐÔ¡£»òÒÔ¸ßÌǸßÖ¬ËÇÁÏÎ¹Ñø´óÊóÒ»¸öÔ£¬ÔÚÓÕµ¼³öÒȵºËضԿ¹ºóÒÔС¼ÁÁ¿STZ    (25mg/kgÌåÖØ)¸¹Ç»×¢É䣬ÓÕ·¢¸ßѪÌÇ¡£¸ßÌÇʳÎï¿ÉÒýÆð´óÊó¸ßÒȵºËØÑªÖ¢£¬¸ßÖ¬·¾Ê³Îï¿Éʹ´óÊóÒÈÏÙÉøÍ¸ÒȵºËع¦Ð§¼õÍ˼°ÌÇÄÍÁ¿½µµÍ¡£¸ßÌǸßÖ¬ÒûʳÓÕ·¢ÒȵºËضԿ¹µÄ»úÖÆ£¬¿ÉÄÜÊÇÓÉÓÚѪÇå¸ÊÓÍÈýõ¥¡¢ÓÎÀëÖ¬·¾Ëá(free fatty acids,FFAs)ˮƽÔö¸ß£¬FFAsͨ¹ýÌÇ£­Ö¬Ñ­»·¡¢ÒȵºËØÐźŴ«µ¼µÈ¶à¸ö;¾¶ÒÖÖÆÌǵÄÖü´æ¡£±ðµÄ£¬ºã¾ÃµÄ¸ßѪÌÇ¿ÉÒÔʹÌåÄÚ¿¹Ñõ»¯¼ÁÌìÉúºÍɨ³ýʧºâ£¬ÒýÆð×é֯ϸ°ûµòÍö¶ø±¬·¢ÆÕ±éËðÉË£¬½µµÍÒȵºËØÃô¸ÐÐÔ£¬×îÖÕµ¼ÖÂÒȵºËضԿ¹µÄ±¬·¢£¬ÔÚÒȵºËضԿ¹µÄÇéÐÎϸøÓèÒ»´ÎС¼ÁÁ¿µÄSTZ¼´¿Éµ¼Ö»úÌåѪÌÇÎÈ̬ʧºâ£¬×îÖÕÒýÆðÌÇÄò²¡¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

Ñ¡ÓÃÐÛÐÔ»ò´ÆÐÔWistar´óÊó£¬ÌåÖØ250g×óÓÒ£¬×¢ÉäSTZ 25~30mg/kg£¨¾²Âö×¢É䣬ÅäÖÆÒªÁìͬǰ£©£¬2¡«3Öܺó²â¶¨ÆÏÌÑÌÇÄÍÁ¿£¬ÌôÑ¡ÌÇÄÍÁ¿Òì³£Õߣ¬Î¹ÒÔ¸ßÖ¬ËÇÁÏ£¨»ù´¡ËÇÁϼÓÊüÌÇ¡¢Á¶ÖíÓÍ¡¢Ïʼ¦µ°µÈ»ìÏý¶ø³É£¬º¬ÂѰ×ÖÊ15%¡«18%£¬Ì¼Ë®»¯ºÏÎï51%~54%£¬Ö¬·¾22%~25%£¬ÈÈÁ¿Îª20.08kJ/g)£¬¶¯Îïµ¥¸öÎ¹Ñø£¬ÒÔ°ü¹Üÿ¸ö¶¯Îï½øÊ³Á¿£¬Î¹10~18ÖÜ¡£Ò»¸öԺ󣬲ⶨ24СʱÉãʳÁ¿¡¢ÌåÖØ¡¢ÑªÑ¹¡¢·Ç½ûʳѪÌÇ¡¢Ñª½¬ÒȵºËØ¡¢Ñª¸ÊÓÍÈýõ¥ºÍµ¨¹Ì´¼Ë®Æ½£¬²¢ÐÐÒȵºËØÒÖÖÆÊÔÑéÒÔÆÀ¼ÛÒȵºËØÃô¸ÐÐÔ¡£

¡¾Ä£×ÓÌØµã¡¿£º

С¼ÁÁ¿STZ¼°¸ßÖ¬ËÇÁÏÎ¹ÑøÊÇÐγɸôóÊóÄ£×ÓµÄÐëÒªÌõ¼þ¡£ÊµÑéÖÜÆÚ¶Ì£¬ÓöȵÍ¡£Óë´¿´â¸ßÄÜÁ¿ËÇÁÏÓÕµ¼µÄ2ÐÍÌÇÄò²¡Ä£×ÓÏà±ÈÏÔÖøËõ¶ÌÁËÓÕµ¼Ê±¼ä£¬Óë´¿´âSTZ×¢ÉäÓÕµ¼µÄ2ÐÍÌÇÄò²¡Ä£×ÓÏà±ÈÏÔÖøÔöÌíÁ˳ÉÄ£ÂÊ£¬Í¬Ê±ÕâÖÖÒªÁìÓÕµ¼µÄ2ÐÍÌÇÄò²¡Ä£×ÓÖ¢×´ºÍ·¢²¡»úÖÆÓëÈËÀà2ÐÍÌÇÄò²¡ºÜÊÇÏàËÆ£¬Òò´ËÊÇÒ»ÖÖ½¨ÉèʵÑéÐÔ2ÐÍÌÇÄò²¡¶¯ÎïÄ£×ÓµÄÓÅÒì;¾¶¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

´óÊó2ÐÍÌÇÄò²¡Ä£×Ó¾ßÓÐÖжȸßѪÌÇ¡¢¸ßѪ֬¡¢¸ßѪѹ¡¢ÒȵºËضԿ¹¡¢ÀÖ³ÉÂʸߵÈÌØµã£¬ÔÚÒ»¶¨Ë®Æ½ÉÏÄ£ÄâÌÇÄò²¡µÄ·¢²¡ÒòËØ¡¢²¡ÀíÀú³ÌºÍÁÙ´²ÌØÕ÷£¬ÊÇÑо¿2ÐÍÌÇÄò²¡Ñª¹Ü²¢·¢Ö¢µÄÀíÏëÄ£×Ó¡£¿ÉÓÃÓÚÑо¿ÌÇÄò²¡µÄ·¢²¡»úÖÆ¼°·ÀÖÎÒªÁì¡£

 

²Î¿¼ÎÄÏ×£º

1.Àî´ÏÈ»£¬ÓÎÑ©¸¦£¬½¯½¨¶«. ÌÇÄò²¡¶¯ÎïÄ£×Ó¼°Ñо¿Ï£Íû. Öйú½ÏÁ¿Ò½Ñ§ÔÓÖ¾£¬2005,15 (1):59-63

2.ÕÅÓñÁ죬Ëﳤò«£®2ÐÍÌÇÄò²¡¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÊÊÓÃÌÇÄò²¡ÔÓÖ¾£¬2011,7(4):7-9

3.ÕÅ´«²Ö£¬ÁõÎÀÅô£¬¶Å½­£¬µÈ£®¸ÄÁ¼ËÄÑõà×ष¨ÖÆ×÷ÌÇÄò²¡¶¯ÎïÄ£×Ó£®ÊÊÓÃҽѧÔÓÖ¾£¬2007,23 (5):623-624

4.³Â½¼Àö£¬ÑîÓ¨£®ÌÇÄò²¡ÊóÄ£×ÓÑо¿ÐÂÏ£Íû£®À¥Ã÷ҽѧԺѧ±¨£¬2012,2:144-146

5.ÕžùÌÏÖ´úÒ©ÀíʵÑéÒªÁì±±¾©£º±±¾©Ò½¿Æ´óѧÖйúЭºÍÒ½¿Æ´óѧÍŽá³öÊéÉ磬1998

6.ÐìÊåÔÆ£¬±åÈç奣¬³ÂÐÞÒ©ÀíʵÑéÒªÁìѧ£®±±¾©£ºÈËÃñÎÀÉú³öÊéÉ磬2005

7.¸ßºìÀò£¬Áõ·½ÓÀ£¬ÏÄ×÷Àí. ʵÑéÐÔÌÇÄò²¡¶¯ÎïÄ£×ÓµÄÀíÂÛÑо¿ÓëÓ¦Óã®ÖйúÁÙ´²¿µ¸´£¬2005,9 (3):210-212

8.Åí·¼£¬ÑîÔ¶»ª. ʵÑéÐÔÌÇÄò²¡¶¯ÎïÄ£×ÓÖÆ±¸¼°Ö¸±ê²â¶¨ÆÀ¼Û. ´óÀíѧԺѧ±¨£¬2003, 2(1): 1-3

9.Aubert R, Herzog J, Camus MC, et al. Description of a new model of genetic obesity: the dbPas mouse. J Nutr, 1985, 115 (3):327-333

10.Hagenieldt-Johansson KA,Herrera PL,Wang H,et al. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor- I alpha induces a maturity­onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology, 2001, 142 (12):5311- 5320

11.Hummel KP, Coleman DL, Lane PW. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL- 6J strains. Biochem Genet, 1972, 7 (1):1-13

12.Kadowaki T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest, 2000, 106(4):459-465

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÄÚÉøÍ¸¼°´úлÐÔ¼²²¡Ä£×Ó > ÓÕ·¢2ÐÍÌÇÄò²¡¶¯ÎïÄ£×Ó
ÓÕ·¢2ÐÍÌÇÄò²¡¶¯ÎïÄ£×Ó

ǰÑÔ

ÌÇÄò²¡(diabetes)ÊÇÒ»ÖÖÒòÌåÄÚÒȵºËؾø¶Ô»òÕßÏà¶Ôȱ·¦Ëùµ¼ÖµÄһϵÁÐÁÙ´²×ÛºÏÕ÷£¬ÓëÒÅ´«»ùÒòÓÐןÜÊÇÇ×½üµÄ¹ØÁª¡£ÓÕ·¢ÌÇÄò²¡ÒòËØºÜÖØ´ó£¬ÔÚ´ó×ÚÈËȺÖÐÑо¿ÆÊÎöÕâЩÒòËØÊ®·ÖÄÑÌ⣬Òò´Ë£¬Ñо¿Ä³Ð©¶¯ÎïÖÖϵÌÇÄò²¡±¬·¢µÄ°Ù·ÖÂʼ°ÇéÐÎÒòËØ£¨Ñ¬È¾¡¢¶¾ËØ¡¢Òûʳ¼°Ò©ÎïµÈ£©¶ÔÓÕ·¢¶¯ÎïÌÇÄò²¡¼°Ä³Ð©²¢·¢Ö¢µÄÓ°Ï죬¿ÉΪ·ÀÖÎÈËÀàÌÇÄò²¡ÌṩÖ÷ÒªÏßË÷¡£¶ø¿¹ÌÇÄò²¡ÐÂÒ©µÄÑо¿£¬Ò²ÐëÏÈÊÔÓÃÓÚÌÇÄò²¡¶¯ÎÒÔÆÀ¼ÛÒ©ÎïµÄÁÆÐ§¼°Çå¾²ÐÔ¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

2ÐÍÌÇÄò²¡(type 2 diabetes)ϵÒÅ´«ÒòËØÓëÇéÐÎÒòËØÅäÏàÖúÓõÄЧ¹û£¬³ýÓÐѪÌÇÉý¸ßÍ⣬ͬʱ¶à°éÓÐѪ֬Òì³£¡£ÏÖÔÚÓÕ·¢2ÐÍÌÇÄò²¡Ä£×ÓÓ¦ÓÃ×îÆÕ±éµÄÊÇÒ©ÎïÒªÁì¡£¸ø´óÊó×¢ÉäС¼ÁÁ¿STZ£¬Ôì³ÉÒȵºβϸ°ûÇá¶ÈËðÉË£¬Ê¹´ó¶¼¶¯Îﱬ·¢ÌÇÄÍÁ¿Òì³££¬ÔÚ´Ë»ù´¡ÉÏ£¬¸ø¶¯Îïι¸ßÈÈÁ¿ËÇÁÏ£¬ÒýÆð¶¯Îï·ÊÅÖ£¬Í¬Ê±°éÓиßѪ֬¡¢¸ßÒȵºËØÑªÖ¢¼°ÒȵºËØ¿¹ÐÔ¡£»òÒÔ¸ßÌǸßÖ¬ËÇÁÏÎ¹Ñø´óÊóÒ»¸öÔ£¬ÔÚÓÕµ¼³öÒȵºËضԿ¹ºóÒÔС¼ÁÁ¿STZ    (25mg/kgÌåÖØ)¸¹Ç»×¢É䣬ÓÕ·¢¸ßѪÌÇ¡£¸ßÌÇʳÎï¿ÉÒýÆð´óÊó¸ßÒȵºËØÑªÖ¢£¬¸ßÖ¬·¾Ê³Îï¿Éʹ´óÊóÒÈÏÙÉøÍ¸ÒȵºËع¦Ð§¼õÍ˼°ÌÇÄÍÁ¿½µµÍ¡£¸ßÌǸßÖ¬ÒûʳÓÕ·¢ÒȵºËضԿ¹µÄ»úÖÆ£¬¿ÉÄÜÊÇÓÉÓÚѪÇå¸ÊÓÍÈýõ¥¡¢ÓÎÀëÖ¬·¾Ëá(free fatty acids,FFAs)ˮƽÔö¸ß£¬FFAsͨ¹ýÌÇ£­Ö¬Ñ­»·¡¢ÒȵºËØÐźŴ«µ¼µÈ¶à¸ö;¾¶ÒÖÖÆÌǵÄÖü´æ¡£±ðµÄ£¬ºã¾ÃµÄ¸ßѪÌÇ¿ÉÒÔʹÌåÄÚ¿¹Ñõ»¯¼ÁÌìÉúºÍɨ³ýʧºâ£¬ÒýÆð×é֯ϸ°ûµòÍö¶ø±¬·¢ÆÕ±éËðÉË£¬½µµÍÒȵºËØÃô¸ÐÐÔ£¬×îÖÕµ¼ÖÂÒȵºËضԿ¹µÄ±¬·¢£¬ÔÚÒȵºËضԿ¹µÄÇéÐÎϸøÓèÒ»´ÎС¼ÁÁ¿µÄSTZ¼´¿Éµ¼Ö»úÌåѪÌÇÎÈ̬ʧºâ£¬×îÖÕÒýÆðÌÇÄò²¡¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

Ñ¡ÓÃÐÛÐÔ»ò´ÆÐÔWistar´óÊó£¬ÌåÖØ250g×óÓÒ£¬×¢ÉäSTZ 25~30mg/kg£¨¾²Âö×¢É䣬ÅäÖÆÒªÁìͬǰ£©£¬2¡«3Öܺó²â¶¨ÆÏÌÑÌÇÄÍÁ¿£¬ÌôÑ¡ÌÇÄÍÁ¿Òì³£Õߣ¬Î¹ÒÔ¸ßÖ¬ËÇÁÏ£¨»ù´¡ËÇÁϼÓÊüÌÇ¡¢Á¶ÖíÓÍ¡¢Ïʼ¦µ°µÈ»ìÏý¶ø³É£¬º¬ÂѰ×ÖÊ15%¡«18%£¬Ì¼Ë®»¯ºÏÎï51%~54%£¬Ö¬·¾22%~25%£¬ÈÈÁ¿Îª20.08kJ/g)£¬¶¯Îïµ¥¸öÎ¹Ñø£¬ÒÔ°ü¹Üÿ¸ö¶¯Îï½øÊ³Á¿£¬Î¹10~18ÖÜ¡£Ò»¸öԺ󣬲ⶨ24СʱÉãʳÁ¿¡¢ÌåÖØ¡¢ÑªÑ¹¡¢·Ç½ûʳѪÌÇ¡¢Ñª½¬ÒȵºËØ¡¢Ñª¸ÊÓÍÈýõ¥ºÍµ¨¹Ì´¼Ë®Æ½£¬²¢ÐÐÒȵºËØÒÖÖÆÊÔÑéÒÔÆÀ¼ÛÒȵºËØÃô¸ÐÐÔ¡£

¡¾Ä£×ÓÌØµã¡¿£º

С¼ÁÁ¿STZ¼°¸ßÖ¬ËÇÁÏÎ¹ÑøÊÇÐγɸôóÊóÄ£×ÓµÄÐëÒªÌõ¼þ¡£ÊµÑéÖÜÆÚ¶Ì£¬ÓöȵÍ¡£Óë´¿´â¸ßÄÜÁ¿ËÇÁÏÓÕµ¼µÄ2ÐÍÌÇÄò²¡Ä£×ÓÏà±ÈÏÔÖøËõ¶ÌÁËÓÕµ¼Ê±¼ä£¬Óë´¿´âSTZ×¢ÉäÓÕµ¼µÄ2ÐÍÌÇÄò²¡Ä£×ÓÏà±ÈÏÔÖøÔöÌíÁ˳ÉÄ£ÂÊ£¬Í¬Ê±ÕâÖÖÒªÁìÓÕµ¼µÄ2ÐÍÌÇÄò²¡Ä£×ÓÖ¢×´ºÍ·¢²¡»úÖÆÓëÈËÀà2ÐÍÌÇÄò²¡ºÜÊÇÏàËÆ£¬Òò´ËÊÇÒ»ÖÖ½¨ÉèʵÑéÐÔ2ÐÍÌÇÄò²¡¶¯ÎïÄ£×ÓµÄÓÅÒì;¾¶¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

´óÊó2ÐÍÌÇÄò²¡Ä£×Ó¾ßÓÐÖжȸßѪÌÇ¡¢¸ßѪ֬¡¢¸ßѪѹ¡¢ÒȵºËضԿ¹¡¢ÀÖ³ÉÂʸߵÈÌØµã£¬ÔÚÒ»¶¨Ë®Æ½ÉÏÄ£ÄâÌÇÄò²¡µÄ·¢²¡ÒòËØ¡¢²¡ÀíÀú³ÌºÍÁÙ´²ÌØÕ÷£¬ÊÇÑо¿2ÐÍÌÇÄò²¡Ñª¹Ü²¢·¢Ö¢µÄÀíÏëÄ£×Ó¡£¿ÉÓÃÓÚÑо¿ÌÇÄò²¡µÄ·¢²¡»úÖÆ¼°·ÀÖÎÒªÁì¡£

 

²Î¿¼ÎÄÏ×£º

1.Àî´ÏÈ»£¬ÓÎÑ©¸¦£¬½¯½¨¶«. ÌÇÄò²¡¶¯ÎïÄ£×Ó¼°Ñо¿Ï£Íû. Öйú½ÏÁ¿Ò½Ñ§ÔÓÖ¾£¬2005,15 (1):59-63

2.ÕÅÓñÁ죬Ëﳤò«£®2ÐÍÌÇÄò²¡¶¯ÎïÄ£×ÓµÄÑо¿Ï£Íû£®ÊÊÓÃÌÇÄò²¡ÔÓÖ¾£¬2011,7(4):7-9

3.ÕÅ´«²Ö£¬ÁõÎÀÅô£¬¶Å½­£¬µÈ£®¸ÄÁ¼ËÄÑõà×ष¨ÖÆ×÷ÌÇÄò²¡¶¯ÎïÄ£×Ó£®ÊÊÓÃҽѧÔÓÖ¾£¬2007,23 (5):623-624

4.³Â½¼Àö£¬ÑîÓ¨£®ÌÇÄò²¡ÊóÄ£×ÓÑо¿ÐÂÏ£Íû£®À¥Ã÷ҽѧԺѧ±¨£¬2012,2:144-146

5.ÕžùÌÏÖ´úÒ©ÀíʵÑéÒªÁì±±¾©£º±±¾©Ò½¿Æ´óѧÖйúЭºÍÒ½¿Æ´óѧÍŽá³öÊéÉ磬1998

6.ÐìÊåÔÆ£¬±åÈç奣¬³ÂÐÞÒ©ÀíʵÑéÒªÁìѧ£®±±¾©£ºÈËÃñÎÀÉú³öÊéÉ磬2005

7.¸ßºìÀò£¬Áõ·½ÓÀ£¬ÏÄ×÷Àí. ʵÑéÐÔÌÇÄò²¡¶¯ÎïÄ£×ÓµÄÀíÂÛÑо¿ÓëÓ¦Óã®ÖйúÁÙ´²¿µ¸´£¬2005,9 (3):210-212

8.Åí·¼£¬ÑîÔ¶»ª. ʵÑéÐÔÌÇÄò²¡¶¯ÎïÄ£×ÓÖÆ±¸¼°Ö¸±ê²â¶¨ÆÀ¼Û. ´óÀíѧԺѧ±¨£¬2003, 2(1): 1-3

9.Aubert R, Herzog J, Camus MC, et al. Description of a new model of genetic obesity: the dbPas mouse. J Nutr, 1985, 115 (3):327-333

10.Hagenieldt-Johansson KA,Herrera PL,Wang H,et al. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor- I alpha induces a maturity­onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology, 2001, 142 (12):5311- 5320

11.Hummel KP, Coleman DL, Lane PW. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. I. C57BL-KsJ and C57BL- 6J strains. Biochem Genet, 1972, 7 (1):1-13

12.Kadowaki T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest, 2000, 106(4):459-465

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿